RVL Pharmaceuticals plc RVLP

NAS: RVLP | ISIN: IE00BF2HDL56   22/12/2023
0,002 USD (+12,15%)
(+12,15%)   22/12/2023

23 oktober 2023 · Thinking about buying stock in Sterling Infrastructure, Mereo BioPharma Group, RVL Pharmaceuticals, SeaStar Medical Holding, or Harpoon Therapeutics? · Persbericht

19 oktober 2023 · Thinking about buying stock in Ardelyx, RVL Pharmaceuticals, Wheeler Real Estate Investment Trust, Troika Media Group, or AT&T? · Persbericht

9 oktober 2023 · Thinking about buying stock in RVL Pharmaceuticals, Maia Biotechnology, Meiwu Technology, Aehr Test Systems, or Tempo Automation Holdings? · Persbericht

6 oktober 2023 · Thinking about buying stock in Camber Energy, RVL Pharmaceuticals, Longeveron, Better Choice Company, or Beneficient? · Persbericht

4 oktober 2023 · Thinking about buying stock in Femasys, micromobility.com, RVL Pharmaceuticals, SeaStar Medical Holding, or Cantaloupe Inc? · Persbericht

3 oktober 2023 · Thinking about buying stock in OpGen Inc, SeaStar Medical Holding, RVL Pharmaceuticals, Terawulf Inc, or Bitfarms Ltd? · Persbericht

2 oktober 2023 · Thinking about buying stock in OpGen Inc, SeaStar Medical Holding, RVL Pharmaceuticals, Terawulf Inc, or Bitfarms Ltd? · Persbericht

3 maart 2021 · Osmotica to Present at Barclays Global Healthcare Conference 2021 · Persbericht

18 februari 2021 · Osmotica to Present at 10th Annual SVB Leerink Global Healthcare Conference · Persbericht

1 februari 2021 · DISCLOSURE UNDER RULE 8.1(a) AND (b)(i) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 · Persbericht

27 januari 2021 · DISCLOSURE UNDER RULE 8.1(a) AND (b)(i) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 · Persbericht

27 januari 2021 · DIRECTOR DISCLOSURE UNDER RULE 8.1(a) AND (b)(i) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 · Persbericht

27 januari 2021 · Rule 2.10 Announcement · Persbericht

Mijn selecties